Now available in the USA

Transforming nail health.

Next-generation phototherapy for moderate to severe onychomycosis. 
Painless • Safe • Peer-reviewed •
Practice changing commercial outcomes
#0
JAPMA accepts ToeFX study for publication
10%
Treatment Response Rate
100+
Partner Clinics Globally
#0
Choice for Severe Onychomycosis
0%
Efficacy Rate for Severe Cases
0%
Patient Satisfaction

ToeFX Phototherapy System

Science Meets Innovation

Safe

Painless

Drug-free

Backed by
clinical studies

No side-effects

Excellent
patient results

Learn More
Book a Demo

Get a copy of our scientific study 

Light Therapy Effectively Treats Onychomycosis and Promotes Healthy Nail Growth in Toenails with Severe Infections: A Longitudinal Cohort Study. Journal of the American Podiatric Medical Association (March 2026, in press)
Get Study Summary

ToeFX Success Stories

Slide to explore how ToeFX transforms toenails - see real results before and after light therapy treatment.

Not just a clinical breakthrough…
Boost your bottom line with cash services that US patients will actually pay for.

$1560

Average hourly rate of clinician time with patient

478%

Year 1 ROI% with only 3 patients per month

8

Total number of patients required to achieve investment payback

Book a 30 min Profit Forecast Meeting with ToeFX Team

What Your Peers Are Saying

Real words from real providers who’ve transformed their
practices with ToeFX.

Real Patients - Remarkable Results!

64 years
Severe infection
Distal-lateral subungual onychomycosis
57 years
Severe infection
Distal-lateral subungual onychomycosis
72 years
High Severity
Distal subungual onychomycosis
51 years
High Severity
Total dystrophic onychomycosis
56 years
High Severity
Total dystrophic onychomycosis
45 years
High Severity
Total dystrophic onychomycosis
34 years
Moderate Severity
Infection for 15 years
Learn More

ToeFX as featured in

PM News

Submit Your Case Now

Get Marketing Materials

Get Study Summary

Become a Partner Clinic

Book Free Consultation